Trials / Conditions / Stage IIIC Esophageal Cancer

Stage IIIC Esophageal Cancer

7 registered clinical trials studyying Stage IIIC Esophageal Cancer.

Status	Trial	Sponsor	Phase
Completed	Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer NCT03154190	Stanford University	N/A
Withdrawn	C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced NCT02344810	Eastern Cooperative Oncology Group	Phase 1 / Phase 2
Unknown	FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients Wit NCT02037048	Case Comprehensive Cancer Center	Phase 2
Completed	Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esop NCT01612546	City of Hope Medical Center	Phase 2
Terminated	Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Meta NCT01705340	National Cancer Institute (NCI)	Phase 1
Completed	Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820	Roswell Park Cancer Institute	Phase 1
Completed	Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal NCT01212822	Fox Chase Cancer Center	Phase 2